101 related articles for article (PubMed ID: 10083171)
1. Fas/Apo-1 expression of human GVHD livers. Bone Marrow Transplantation Group.
Wakabayashi T; Onoda H; Masunaga A
Transplant Proc; 1999; 31(1-2):423-4. PubMed ID: 10083171
[No Abstract] [Full Text] [Related]
2. Apoptosis and the expression of Fas and Fas-ligand antigen after orthotopic liver transplantation.
Tannapfel A; Kohlhaw K; Schwarz R; Wenzke M; Köckerling F; Ebelt J; Hauss J; Wittekind C
Transplant Proc; 1998 Aug; 30(5):2358-9. PubMed ID: 9723503
[No Abstract] [Full Text] [Related]
3. Early detection of the Fas-FasL system in hepatic graft-versus-host disease after rat small-bowel transplantation.
Shiraishi M; Hiroyasu S; Koji T; Muto Y; Koyama Y
Transplant Proc; 1999; 31(1-2):567-8. PubMed ID: 10083239
[No Abstract] [Full Text] [Related]
4. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
[TBL] [Abstract][Full Text] [Related]
5. Blockade of programmed death-1 engagement accelerates graft-versus-host disease lethality by an IFN-gamma-dependent mechanism.
Blazar BR; Carreno BM; Panoskaltsis-Mortari A; Carter L; Iwai Y; Yagita H; Nishimura H; Taylor PA
J Immunol; 2003 Aug; 171(3):1272-7. PubMed ID: 12874215
[TBL] [Abstract][Full Text] [Related]
6. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
[TBL] [Abstract][Full Text] [Related]
7. The role of p53 and Fas in a model of acute murine graft-versus-host disease.
Yada S; Takamura N; Inagaki-Ohara K; O'leary MK; Wasem C; Brunner T; Green DR; Lin T; Pinkoski MJ
J Immunol; 2005 Feb; 174(3):1291-7. PubMed ID: 15661885
[TBL] [Abstract][Full Text] [Related]
8. Expression of Fas/Fas ligand and apoptosis induction during renal allograft rejection.
Matsuno T; Sasaki H; Nakagawa K; Okada Y; Endo A; Fujiwara T; Oishi M; Saito S; Yagi T; Haisa M; Tanaka N
Transplant Proc; 1998 Nov; 30(7):2947-9. PubMed ID: 9838299
[No Abstract] [Full Text] [Related]
9. Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.
Blazar BR; Lees CJ; Martin PJ; Noelle RJ; Kwon B; Murphy W; Taylor PA
J Immunol; 2000 Nov; 165(9):4901-9. PubMed ID: 11046015
[TBL] [Abstract][Full Text] [Related]
10. Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome.
Gersuk GM; Lee JW; Beckham CA; Anderson J; Deeg HJ
Blood; 1996 Aug; 88(3):1122-3. PubMed ID: 8704224
[No Abstract] [Full Text] [Related]
11. [Effects of Interleukin-10 on the proliferation and Fas/Fas ligand expression of hepatic stellate cells].
Chen YX; Wang XZ; Weng SG; Chen ZX; Huang YH; Zhang LJ
Zhonghua Gan Zang Bing Za Zhi; 2003 Oct; 11(10):637, 640. PubMed ID: 14572356
[No Abstract] [Full Text] [Related]
12. Cross species graft-versus-host disease induces hepatic injury in association with a donor-derived cellular immune response.
Cooper MH; Nalesnik MA; Watkins SC; Schachter MJ; Ildstad ST
Transplant Proc; 1993 Feb; 25(1 Pt 2):1283. PubMed ID: 8442113
[No Abstract] [Full Text] [Related]
13. Donor T cells lacking Fas ligand and perforin retain the capacity to induce severe GvHD in minor histocompatibility antigen mismatched bone-marrow transplantation recipients.
Marks L; Altman NH; Podack ER; Levy RB
Transplantation; 2004 Mar; 77(6):804-12. PubMed ID: 15077018
[TBL] [Abstract][Full Text] [Related]
14. Immunopathogenesis of GVHD.
Imamura M; Tanaka J; Hashino S; Kobayashi S; Imai K; Asaka M; Kasai M
Transplant Proc; 1996 Jun; 28(3):1181-3. PubMed ID: 8658619
[No Abstract] [Full Text] [Related]
15. Antibodies to hepatocyte derived antigens and liver damage in patients after bone marrow transplantation.
Borzì RM; Meliconi R; Conte R; Bandini G; Ricci P; Miglio F; Facchini A; Gasbarrini G
Allergol Immunopathol (Madr); 1991; 19(2):63-8. PubMed ID: 1772106
[TBL] [Abstract][Full Text] [Related]
16. Difference in the expression of Fas/Fas-ligand and the lymphocyte subset reconstitution according to the occurrence of acute GVHD.
Lee S; Chong SY; Lee JW; Kim SC; Min YH; Hahn JS; Ko YW
Bone Marrow Transplant; 1997 Nov; 20(10):883-8. PubMed ID: 9404931
[TBL] [Abstract][Full Text] [Related]
17. The role of cell-mediated cytotoxicity in acute GVHD after MHC-matched allogeneic bone marrow transplantation in mice.
Baker MB; Altman NH; Podack ER; Levy RB
J Exp Med; 1996 Jun; 183(6):2645-56. PubMed ID: 8676085
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host disease: liver morphology and pheno/genotypes of inflammatory cells and target cells in sex-mismatched allogeneic bone marrow transplant patients.
Andersen CB; Horn T; Sehested M; Junge J; Jacobsen N
Transplant Proc; 1993 Feb; 25(1 Pt 2):1250-4. PubMed ID: 8442105
[No Abstract] [Full Text] [Related]
19. Effect of graft-versus-host disease (GVHD) on host hematopoietic progenitor cells is mediated by Fas-Fas ligand interactions but this does not explain the effect of GVHD on donor cells.
Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Sugihara A; Terada N; Fujimoto J; Kakishita E
Cell Immunol; 1999 Oct; 197(1):30-8. PubMed ID: 10555993
[TBL] [Abstract][Full Text] [Related]
20. Skin biopsies for early diagnosis and prognosis of graft-versus-host disease in recipients of allogeneic stem cells from blood or bone marrow.
Heldal D; Brinch L; Evensen SA; Tjønnfjord GE; Aamodt G; Elgjo K; Sviland L
Bone Marrow Transplant; 2004 Aug; 34(4):345-50. PubMed ID: 15170163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
